|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/24 | |||
| A61K 9/28 | |||
| A61K 31/513 | |||
| A61K 31/675 | |||
| A61P 31/18 |
| (11) | Patento numeris | 3316868 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16739625.8 |
| Europos patento paraiškos padavimo data | 2016-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/040158 |
| Data | 2016-06-29 |
| (87) | Numeris | WO 2017/004244 |
| Data | 2017-01-05 |
| (30) | Numeris | Data | Šalis |
| 201562187113 P | 2015-06-30 | US | |
| 201662298373 P | 2016-02-22 | US | |
| 201662301429 P | 2016-02-29 | US | |
| 201662317286 P | 2016-04-01 | US |
| (72) |
KOZIARA, Joanna, M., US
MCCALLISTER, Scott, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR AND EMTRICITABINE |
| PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR AND EMTRICITABINE |